Exubera Inhaled Insulin Gets Favorable Committee Review In Europe
This article was originally published in The Pink Sheet Daily
Executive Summary
European Medicines Agency's Committee for Medicinal Products for Human Use recommends approval of Pfizer/Sanofi's agent for type 1 and 2 diabetes with post-market monitoring for pulmonary function decline and hypoglycemia.